Showing 2891-2900 of 5909 results for "".
- Alcon Contact Lens and Cataract Innovations to Headline Clinical and Educational Program at #Academy19https://modernod.com/news/alcon-contact-lens-and-cataract-innovations-to-headline-clinical-and-educational-program-at-academy19/2477022/Alcon will bring major contact lens and cataract innovations together for the first time at the 2019 American Academy of Optometry (AAO / #Academy19) meeting taking place October 23-27 at the Orange County Convention Center (OCCC) in Orlando, according to a company news release. Innovations like
- Optos Unveils Silverstone Combined Ultra-Widefield Retinal Imaging Device and UWF-Guided Swept Source OCThttps://modernod.com/news/optos-unveils-silverstone-combined-ultra-widefield-retinal-imaging-device-and-uwf-guided-swept-source-oct/2476998/Optos has announced the launch of Silverstone at the American Academy of Ophthalmology in San Francisco. Silverstone is the first-of-its-kind, combining world-leading ultra-widefield retinal imaging with integrated, image-guided, swept source OCT. Silverstone produces a 200° single capture
- Norlase Enters Ophthalmic Market With Launch of LEAF Ultra-Compact Green Laser Photocoagulatorhttps://modernod.com/news/norlase-enters-ophthalmic-market-with-launch-of-leaf-ultra-compact-green-laser-photocoagulator/2476999/Norlase announced the FDA 510(k) clearance and immediate commercial launch of LEAF, the company’s flagship laser product for the treatment of retina and glaucoma disease. LEAF allows ophthalmologists to perform laser therapy in almost any exam room, with minimal set-up time and physical space req
- eSight 3 Approved on the US Department of Veterans Affairs (VA) Federal Supply Schedulehttps://modernod.com/news/esight-3-approved-on-the-us-department-of-veterans-affairs-va-federal-supply-schedule/2476985/eSight announced the approval of eSight 3–advanced sight-enhancing glasses for those living with visual impairments–on the United States Department of Veterans Affairs (VA) Federal Supply Schedule (FSS). The registration allows eSight to be included on the FSS through December 2023.<
- Injectsense Demonstrates Animal-to-Cloud IOP Sensing Pathway for Glaucomahttps://modernod.com/news/injectsense-demonstrates-animal-to-cloud-iop-sensing-pathway-for-glaucoma/2476964/Injectsense announced completion of a successful in-vivo animal study of the first implantable sensor and monitoring system designed to collect long-term IOP data. The Injectsense IOP-Connect system creates an organ-to-cloud data connection that enables the clinician to assess glaucoma therapy ef
- Zeiss and Senorics Establish Partnership Focus on Joint Development of Sensor Technologyhttps://modernod.com/news/zeiss-and-senorics-establish-partnership-focus-on-joint-development-of-sensor-technology/2476952/Zeiss announced that it has invested in Dresden, Germany-based Senorics. The partnership aims to further the joint development of small and cost-effective sensors for industrial use in quality assurance and in process monitoring, e.g. on production lines for foodstuffs, agricultural products, pla
- CorneaGen Raises $37 Million to Advance Development of Cornea Cell Therapyhttps://modernod.com/news/corneagen-raises-37-million-to-advance-development-of-cornea-cell-therapy/2476950/CorneaGen announced the closing of a $37 million Series B financing. The round was led by Flying L Partners in collaboration with Falcon Vision, a platform formed by KKR to advance innovation in ophthalmology. Petrichor Healthcare Capital Management also participated in the equity round and provi
- CorneaGen Raises $37 Million to Advance Development of Cornea Cell Therapyhttps://modernod.com/news/corneagen-raises-37-million-to-advance-development-of-cornea-cell-therapy/2476948/CorneaGen announced the closing of a $37 million Series B financing. The round was led by Flying L Partners in collaboration with Falcon Vision, a platform formed by KKR to advance innovation in ophthalmology. Petrichor Healthcare Capital Management also participated significantly in the equity r
- FDA Approval Granted for Eyeris Novel Contact Lenshttps://modernod.com/news/fda-approval-granted-for-eyeris-novel-contact-lens/2476946/Eyeris, a Nashville, Tennessee start-up, announced that it has closed its second round of funding and secured FDA approval for their daily disposable contact lens, which will become available in
- Johns Hopkins Researchers Advance Search For Safer, Easier Way to Deliver Vision-Saving Gene Therapy to The Retinahttps://modernod.com/news/johns-hopkins-researchers-advance-search-for-safer-easier-way-to-deliver-vision-saving-gene-therapy-to-the-retina/2476942/In experiments with rats, pigs, and monkeys, Johns Hopkins Medicine researchers have developed a way to deliver sight-saving gene therapy to the retina. If proved safe and effective in humans, the technique could provide a new, more permanent therapeutic option for patients